JPJatta Pirkola

Jatta Pirkola

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jatta Pirkola has a total of 25 co-authors. Here are the top co-authors by number of shared publications:

  • Aini Bloigu

    Child and Adolescent Health and Wellbeing Unit, National Institute for Health and Welfare, Oulu, Finland

    4 shared publications
  • Marjo-Riitta Järvelin

    Research Unit of Population Health, Faculty of Medicine, University of Oulu, Oulu, Finland

    4 shared publications
  • Anna-Liisa Hartikainen

    Department of Obstetrics and Gynecology, Oulu University Hospital, Oulu, Finland

    3 shared publications
  • Anneli Pouta

    Child and Adolescent Health and Wellbeing Unit, National Institute for Health and Welfare, Oulu, Finland

    3 shared publications
  • Marja Vääräsmäki

    Department of Obstetrics and Gynecology, Oulu University Hospital, Oulu, Finland

    3 shared publications
  • Satu Miettola

    Department of Obstetrics and Gynecology (J.P., S.M., A.-L.H., M.V.), Oulu University Hospital, 90029 Oulu, Finland 2 Child and Adolescent Wellbeing Unit (J.P., A.P., A.B., S.M., M.-R.J.), National Institute for Health and Welfare, 90101 Oulu, Finland

    2 shared publications

Latest Publications

  • Open Access

    Risks of Overweight and Abdominal Obesity at Age 16 Years Associated With Prenatal Exposures to Maternal Prepregnancy Overweight and Gestational Diabetes Mellitus

    by Jatta Pirkola, Anneli Pouta, Aini Bloigu, Anna-Liisa Hartikainen, Jaana Laitinen, Marjo-Riitta Järvelin, Marja Vääräsmäki

    OBJECTIVE: The associations of prenatal exposures to maternal prepregnancy overweight and gestational diabetes mellitus (GDM) with offspring overweight are controversial. Research estimating risk for offspring overweight due to these exposures, separately and concomitantly, is limited. RESEARCH DESIGN AND METHODS: Prevalence of overweight and abdominal obesity at age 16 years and odds ratios (ORs) for prenatal exposures to maternal prepregnancy overweight and GDM were estimated in participants of the prospective longitudinal Northern Finland Birth Cohort of 1986 (N = 4,168). RESULTS: The prevalence and estimates of risk for overweight and abdominal obesity were highest in those exposed to both maternal prepregnancy overweight and GDM (overweight prevalence 40% [OR 4.05], abdominal obesity prevalence 25.7% [3.82]). Even in offspring of mothers with a normal oral glucose tolerance test during pregnancy, maternal prepregnancy overweight is associated with increased risk for these outcomes (overweight prevalence 27.9% [2.56], abdominal obesity prevalence 19.5% [2.60]). In offspring of women with prepregnancy normal weight, the prevalence or risks of the outcomes were not increased by prenatal exposure to GDM. These estimates of risk were adjusted for parental prepregnancy smoking, paternal overweight, and offspring sex and size at birth. CONCLUSIONS: Maternal prepregnancy overweight is an independent risk factor for offspring overweight and abdominal obesity at age 16 years. The risks are highest in offspring with concomitant prenatal exposure to maternal prepregnancy overweight and GDM, whereas the risks associated with GDM are only small.


  • Open Access

    Prepregnancy Overweight and Gestational Diabetes as Determinants of Subsequent Diabetes and Hypertension after 20-Year Follow-Up

    by Jatta Pirkola, Anneli Pouta, Aini Bloigu, Satu Miettola, Anna-Liisa Hartikainen, Marjo-Riitta Järvelin, Marja Vääräsmäki

    Context: Overweight is a strong risk factor for gestational diabetes (GDM), and both states indicate increased risk for subsequent metabolic syndrome. Data separating effects of overweight and GDM on risk for metabolic diseases are limited. Objective: The aim of the study was to evaluate prepregnancy overweight and GDM as determinants of risk for subsequent diabetes and hypertension. Design: Population-based data from the Northern Finland Birth Cohort 1986 were compounded with register-based data on diagnosis of diabetes and hypertension. Setting: The study was conducted in Northern Finland. Participants: We studied: 1) normal-weight women with GDM (n = 70); 2) overweight women with GDM (n = 54); 3) normal-weight (n = 768) and 4) overweight (n = 250) women with risk factors for GDM but normal oral glucose tolerance test results; and 5) women with no risk factors for GDM (n = 5341). Main Outcome Measures: We measured cumulative incidence of diabetes and hypertension, hazard ratio (HR), and population-attributable fraction (PAF) for determinants of risk. Results: The cumulative incidence of diagnosed diabetes and hypertension in the whole study population was 1.3 and 7.5%, respectively. Concomitant overweight and GDM indicated high risks for diabetes (HR, 47.24; PAF, 15.8%) and hypertension (HR, 9.16; PAF, 4.4%). Even when the OGTT in pregnancy was normal, prepregnancy overweight associated with risks for diabetes (HR, 12.63; PAF, 22.2%) and hypertension (HR, 2.86; PAF, 6.0%). In normal-weight women, GDM indicated risk for diabetes (HR, 10.61; PAF, 5.2%) but not for hypertension. Conclusions: Prepregnancy overweight is an essential risk factor for subsequent diabetes and hypertension, especially when combined with GDM.


  • Open Access

    Low-Grade, Systemic Inflammation in Adolescents: Association With Early-Life Factors, Gender, and Lifestyle

    by Jatta Pirkola, Marja Vääräsmäki, Mika Ala-Korpela, Aini Bloigu, Dexter Canoy, Anna-Liisa Hartikainen, Maija Leinonen, Satu Miettola, Mika Paldanius, Tuija H. Tammelin, et al.

    Low-grade, systemic inflammation is related to increased risk of cardiovascular disease in adults. The proinflammatory state tracks from adolescence to adulthood. Identifying correlates of inflammation in adolescents could provide opportunities to prevent cardiovascular disease in adulthood. However, population-based data on correlates of inflammation in adolescence are limited. Therefore, the authors studied the associations of early-life factors, gender, and lifestyle with inflammation (measured by high-sensitivity C-reactive protein and leukocyte count) at age 16 years (2001–2002) in the prospective, population-based Northern Finland Birth Cohort 1986 Study (n = 5,240). In females, being born small for gestational age and current use of oral contraceptives were associated with the proinflammatory state. The association of birth size with inflammation was not observed in males. In logistic regression analyses, oral contraceptive use (odds ratio (OR) = 2.83), abdominal obesity (OR = 5.17), and smoking (OR = 2.72) were associated with elevation of both inflammation markers in females; abdominal obesity (OR = 5.72) and smoking (OR = 2.02) were associated in males. Thus, females appear more susceptible to the adverse effects of being born small for gestational age than males. Given the widespread use of oral contraceptives and the potential pathophysiologic consequences of the proinflammatory state, the association of oral contraceptive use with inflammation in adolescence may have public health implications.


  • Maternal type 1 and gestational diabetes: postnatal differences in insulin secretion in offspring at preschool age

    by Jatta Pirkola, Marja Vääräsmäki, Erja Leinonen, Aini Bloigu, Riitta Veijola, Päivi Tossavainen, Mikael Knip, Päivi Tapanainen

    It is well known that children born to mothers with diabetes in pregnancy are more likely to develop metabolic abnormalities in later life. Most prior studies have not differentiated between offspring of mothers with type 1 diabetes (T1DM) and gestational diabetes (GDM) or lack a control group of non-exposed offspring. Offspring of T1DM (n = 16), GDM (n = 22) and mothers without diabetes (n = 25) born at Oulu University Hospital. To assess insulin secretion and insulin resistance in the offspring of T1DM and GDM at preschool age in comparison with offspring of non-diabetic mothers. Anthropometric measurements and intravenous glucose tolerance testing were performed. First-phase insulin response (FPIR) and homoeostasis model assessment (HOMA) values were calculated. Pregnancy and birth data were analysed in relation to later metabolic parameters in all three groups using one-way analysis of variance (ANOVA) and analysis of covariance (ANCOVA). At a mean age of 4.9 yr, offspring of T1DM had increased fasting serum insulin concentrations (p = 0.044), FPIR (p = 0.034) and HOMA-B values (p = 0.008) compared with offspring of GDM or with offspring of healthy controls (statistically non-significant). The GDM gained least weight during pregnancy, and when adjusted for maternal weight gain during pregnancy, there were no statistically significant differences between study groups. Prenatal exposures to maternal type 1 and gestational diabetes may have different effects on postnatal glucose metabolism in the offspring assessed at a mean age close to 5 yr. Maternal weight gain in pregnancy may affect the postnatal glucose metabolism in the offspring.


  • Prevalence of metabolic syndrome at age 16 using the International Diabetes Federation paediatric definition

    by J Pirkola, T Tammelin, A Bloigu, A Pouta, J Laitinen, A Ruokonen, P Tapanainen, M-R Jarvelin, M Vaarasmaki

    Objective: We estimated the prevalence of metabolic syndrome (MS) in adolescents, using the new International Diabetes Federation (IDF) paediatric definition and compared this with prevalence estimated using the IDF adult definition and five other previously published definitions. Design: Cross-sectional survey in the prospective general population-based Northern Finland Birth Cohort 1986 (NFBC 1986) at age 16 years. Setting: Birth cohort in Finland. Participants: 5665 adolescents (2862 males and 2803 females) clinically examined in 2001-2002. Main outcome measures: The prevalence of MS using different definitions. Results: The overall prevalence of MS using the IDF paediatric definition was 2.4% (95% CI 2.0 to 2.8%) at the age of 16 years. Using the IDF adult definition the overall prevalence was lower, 1.7% (CI 1.3 to 2.0%, European cut-offs for waist circumference) and 1.0% (CI 0.7 to 1.3%, North American cut-offs). Conclusion: In 16-year-old adolescents, the paediatric IDF definition rendered a higher prevalence estimate than the adult definition.